Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial
Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page
- Check3 days agoChange DetectedRevision indicator on the page was updated to v3.6.5, signaling a new version of the page's content/template.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRepresents a minor version bump in the site's revision metadata from v3.6.3 to v3.6.4. This indicates an update to the page's underlying versioning.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision tag on the page was updated to v3.6.3, replacing the previous v3.6.0. This reflects a new page version without altering the study details presented.SummaryDifference0.0%

- Check59 days agoChange DetectedThe study page now shows recruitment closed with 'No longer looking for participants'. New helper sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header was updated, and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check67 days agoChange DetectedThe page shows a platform revision from v3.5.4 to v3.5.5, indicating a small update to the site that does not change the study details.SummaryDifference0.0%

- Check88 days agoChange DetectedThe revision label on the page updated from v3.5.3 to v3.5.4, indicating a software update to the site's interface.SummaryDifference0.0%

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.